Shinpoong Pharmaceutical, Top Search Ranking... Stock Price -3.2%
As of 12:32 PM on the 18th, Shinpung Pharmaceutical is trading at 19,650 KRW, down 3.2% from the previous day. This represents a 24.37% increase compared to April 16. Shinpung Pharmaceutical is known as a pharmaceutical company focused on the sale of specialized therapeutic drugs.
Over the past five days, individual investors have net purchased 8,652 shares, while foreigners and institutions have net sold 8,711 shares and net purchased 21,326 shares, respectively.
On May 14, Shinpung Pharmaceutical became a market topic with the announcement of "Malaria treatment drug COVID-19 Phase 2 clinical trial approval (comprehensive)."

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Experts Shocked by Record Numbers: "Just the Tip of the Iceberg" — The Identity Behind the 90% Dominating Teens [Chuiyakgukga]⑨
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- Strong First-Quarter Earnings for Listed Firms Even Without Samsung and SK hynix
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.